Erickson J, Dalton B, Paucker K
Arch Virol. 1980; 63(3-4):253-61.
PMID: 7356397
DOI: 10.1007/BF01315031.
Allen G
Biochem J. 1982; 207(3):397-408.
PMID: 7165700
PMC: 1153878.
DOI: 10.1042/bj2070397.
Salit M, OGBURN C
Arch Virol. 1980; 63(2):133-42.
PMID: 6243919
DOI: 10.1007/BF01320770.
Meurs E, Rougeot C, Svab J, Laurent A, Hovanessian A, Robert N
Infect Immun. 1982; 37(3):919-26.
PMID: 6182105
PMC: 347626.
DOI: 10.1128/iai.37.3.919-926.1982.
Braude I, Lin L, Stewart 2nd W
Biochem J. 1981; 193(3):947-51.
PMID: 6171256
PMC: 1162689.
DOI: 10.1042/bj1930947.
Differences between human alpha (leukocyte) and beta (fibroblast) interferons.
Hayes T
Arch Virol. 1981; 67(4):267-81.
PMID: 6165341
DOI: 10.1007/BF01314831.
The reactivation of human interferons by guanidine thiocyanate.
Jariwalla R, Sedmak J, Grossberg S
Experientia. 1980; 36(12):1390-1.
PMID: 6162669
DOI: 10.1007/BF01960115.
Enzymatic modifications of human fibroblast and leukocyte interferons.
Otto M, Sedmak J, Grossberg S
J Virol. 1980; 35(2):390-9.
PMID: 6160260
PMC: 288823.
DOI: 10.1128/JVI.35.2.390-399.1980.
Nature of the molecular heterogeneity of human leukocyte interferon.
Chen J, Jankowski W, OMalley J, SULKOWSKI E, CARTER W
J Virol. 1976; 19(2):425-34.
PMID: 957478
PMC: 354880.
DOI: 10.1128/JVI.19.2.425-434.1976.
Characterization of the size and charge heterogeneities of human leukocyte interferon populations.
Lin L, Chudizio T, Stewart 2nd W
Arch Virol. 1978; 56(3):269-72.
PMID: 637729
DOI: 10.1007/BF01317857.
Production of antibodies to human interferons in mice.
Dalton B, OGBURN C, Paucker K
Infect Immun. 1978; 19(2):570-4.
PMID: 631890
PMC: 414121.
DOI: 10.1128/iai.19.2.570-574.1978.
Human leukocyte interferon: relationship between molecular structure and species specificity.
THANG M, Thang D, Chelbi-Alix M, CHANY C
Proc Natl Acad Sci U S A. 1979; 76(8):3717-21.
PMID: 291036
PMC: 383904.
DOI: 10.1073/pnas.76.8.3717.
Human leukocyte interferon: production, purification to homogeneity, and initial characterization.
Rubinstein M, Rubinstein S, Familletti P, Miller R, Waldman A, Pestka S
Proc Natl Acad Sci U S A. 1979; 76(2):640-4.
PMID: 284389
PMC: 383004.
DOI: 10.1073/pnas.76.2.640.
Synthesis of human interferon by Xenopus laevis oocytes: two structural genes for interferons in human cells.
Cavalieri R, Havell E, Vilcek J, Pestka S
Proc Natl Acad Sci U S A. 1977; 74(8):3287-91.
PMID: 269391
PMC: 431533.
DOI: 10.1073/pnas.74.8.3287.
Monkey interferon: activity on human cells and chromatographic properties. Brief report.
Yakobson E, Revel M, Gurari-Rotman D
Arch Virol. 1979; 59(3):251-5.
PMID: 222238
DOI: 10.1007/BF01317420.
Interferoids: in vitro and in vivo conversion of native interferons to lower molecular weight forms.
Stewart 2nd W, Chudzio T, Lin L
Proc Natl Acad Sci U S A. 1978; 75(10):4814-8.
PMID: 217001
PMC: 336211.
DOI: 10.1073/pnas.75.10.4814.
Elimination of size and charge heterogeneities of human leukocyte interferons by chemical cleavage.
Stewart 2nd W, Lin L, Cantell K
Proc Natl Acad Sci U S A. 1977; 74(10):4200-4.
PMID: 200907
PMC: 431906.
DOI: 10.1073/pnas.74.10.4200.
Correlation of physicochemical and antigenic properties of human leukocyte interferon subspecies.
Havell E, Yip Y, Vilcek J
Arch Virol. 1977; 55(1-2):121-9.
PMID: 72554
DOI: 10.1007/BF01314485.
Multiple active sites on human interferons.
Paucker K, Dalton B, OGBURN C, Torma E
Proc Natl Acad Sci U S A. 1975; 72(11):4587-91.
PMID: 53841
PMC: 388768.
DOI: 10.1073/pnas.72.11.4587.
